|
1
|
Bray F, Laversanne M, Sung H, Ferlay J,
Siegel RL, Soerjomataram I and Jemal A: Global cancer statistics
2022: GLOBOCAN estimates of incidence and mortality worldwide for
36 cancers in 185 countries. CA Cancer J Clin. 74:229–263.
2024.PubMed/NCBI
|
|
2
|
Wang X, Zhang L and Dong B: Molecular
mechanisms in MASLD/MASH-related HCC. Hepatology. 8:1303–1324.
2025. View Article : Google Scholar
|
|
3
|
Foerster F, Gairing SJ, Müller L and Galle
PR: NAFLD-driven HCC: Safety and efficacy of current and emerging
treatment options. J Hepatol. 76:446–457. 2022. View Article : Google Scholar
|
|
4
|
Toh MR, Wong EYT, Wong SH, Ng AWT, Loo LH,
Chow PK and Ngeow J: Global epidemiology and genetics of
hepatocellular carcinoma. Gastroenterology. 164:766–782. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Childs A, Aidoo-Micah G, Maini MK and
Meyer T: Immunotherapy for hepatocellular carcinoma. JHEP Rep.
6:1011302024. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Medavaram S and Zhang Y: Emerging
therapies in advanced hepatocellular carcinoma. Exp Hematol Oncol.
7:172018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rimassa L, Pressiani T and Merle P:
Systemic treatment options in hepatocellular carcinoma. Liver
Cancer. 8:427–446. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Artero-Castro A, Castellvi J, García A,
Hernández J, Ramón Y, Cajal S and Lleonart ME: Expression of the
ribosomal proteins Rplp0, Rplp1, and Rplp2 in gynecologic tumors.
Hum Pathol. 42:194–203. 2011. View Article : Google Scholar
|
|
9
|
Artero-Castro A, Perez-Alea M, Feliciano
A, Leal JA, Genestar M, Castellvi J, Peg V, Ramón Y, Cajal S and
Lleonart ME: Disruption of the ribosomal P complex leads to
stress-induced autophagy. Autophagy. 11:1499–1519. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Teller A, Jechorek D, Hartig R, Adolf D,
Reißig K, Roessner A and Franke S: Dysregulation of apoptotic
signaling pathways by interaction of RPLP0 and cathepsin X/Z in
gastric cancer. Pathol Res Pract. 211:62–70. 2015. View Article : Google Scholar
|
|
11
|
Wang CH, Wang LK, Wu CC, Chen ML, Lee MC,
Lin YY and Tsai FM: The ribosomal protein RPLP0 mediates
PLAAT4-induced cell cycle arrest and cell apoptosis. Cell Biochem
Biophys. 77:253–260. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang YL, Zhao WW, Bai SM, Ma Y, Yin XK,
Feng LL, Zeng GD, Wang F, Feng WX, Zheng J, et al: DNA
damage-induced paraspeckle formation enhances DNA repair and tumor
radioresistance by recruiting ribosomal protein P0. Cell Death Dis.
13:7092022. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Debnath J, Gammoh N and Ryan KM: Autophagy
and autophagy-related pathways in cancer. Nat Rev Mol Cell Biol.
24:560–575. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Miller DR and Thorburn A: Autophagy and
organelle homeostasis in cancer. Dev Cell. 56:906–918. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Meng Y, Huang X, Zhang G, Fu S, Li Y, Song
J, Zhu Y, Xu X and Peng X: MicroRNA-450b-5p modulated RPLP0
promotes hepatocellular carcinoma progression via activating
JAK/STAT3 pathway. Transl Oncol. 50:1021502024. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zheng P, Xu D, Cai Y, Zhu L, Xiao Q, Peng
W and Chen B: A multi-omic analysis reveals that Gamabufotalin
exerts anti-hepatocellular carcinoma effects by regulating amino
acid metabolism through targeting STAMBPL1. Phytomedicine.
135:1560942024. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
18
|
Qian J, Wang Q, Xiao L, Xiong W, Xian M,
Su P, Yang M, Zhang C, Li Y, Zhong L, et al: Development of
therapeutic monoclonal antibodies against DKK1 peptide-HLA-A2
complex to treat human cancers. J Immunother Cancer.
12:e0081452024. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mizushima N and Komatsu M: Autophagy:
Renovation of cells and tissues. Cell. 147:728–741. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mizushima N and Levine B: Autophagy in
human diseases. N Engl J Med. 383:1564–1576. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yan LS, Zhang SF, Luo G, Cheng BC, Zhang
C, Wang YW, Qiu XY, Zhou XH, Wang QG, Song XL, et al: Schisandrin B
mitigates hepatic steatosis and promotes fatty acid oxidation by
inducing autophagy through AMPK/mTOR signaling pathway. Metabolism.
131:1552002022. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhao YG, Codogno P and Zhang H: Machinery,
regulation and pathophysiological implications of autophagosome
maturation. Nat Rev Mol Cell Biol. 22:733–750. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Miao CC, Hwang W, Chu LY, Yang LH, Ha CT,
Chen PY, Kuo MH, Lin SC, Yang YY, Chuang SE, et al: LC3A-mediated
autophagy regulates lung cancer cell plasticity. Autophagy.
18:921–934. 2022. View Article : Google Scholar :
|
|
24
|
Bradford HF, McDonnell TCR, Stewart A,
Skelton A, Ng J, Baig Z, Fraternali F, Dunn-Walters D, Isenberg DA,
Khan AR, et al: Thioredoxin is a metabolic rheostat controlling
regulatory B cells. Nat Immunol. 25:873–885. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ornatowski W, Lu Q, Yegambaram M, Garcia
AE, Zemskov EA, Maltepe E, Fineman JR, Wang T and Black SM: Complex
interplay between autophagy and oxidative stress in the development
of pulmonary disease. Redox Biol. 36:1016792020. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Russell RC and Guan KL: The multifaceted
role of autophagy in cancer. EMBO J. 41:e1100312022. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yang R, Gao W, Wang Z, Jian H, Peng L, Yu
X, Xue P, Peng W, Li K and Zeng P: Polyphyllin I induced
ferroptosis to suppress the progression of hepatocellular carcinoma
through activation of the mitochondrial dysfunction via
Nrf2/HO-1/GPX4 axis. Phytomedicine. 122:1551352024. View Article : Google Scholar
|
|
28
|
Tsai HY, Bronner MP, March JK, Valentine
JF, Shroyer NF, Lai LA, Brentnall TA, Pan S and Chen R: Metabolic
targeting of NRF2 potentiates the efficacy of the TRAP1 inhibitor
G-TPP through reduction of ROS detoxification in colorectal cancer.
Cancer Lett. 549:2159152022. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Johnson DE, O'Keefe RA and Grandis JR:
Targeting the IL-6/JAK/STAT3 signalling axis in cancer. Nat Rev
Clin Oncol. 15:234–248. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lai SY and Johnson FM: Defining the role
of the JAK-STAT pathway in head and neck and thoracic malignancies:
Implications for future therapeutic approaches. Drug Resist Updat.
13:67–78. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yu H, Lee H, Herrmann A, Buettner R and
Jove R: Revisiting STAT3 signalling in cancer: new and unexpected
biological functions. Nat Rev Cancer. 14:736–746. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chen L, Zhang C, Xue R, Liu M, Bai J, Bao
J, Wang Y, Jiang N, Li Z, Wang W, et al: Deep whole-genome analysis
of 494 hepatocellular carcinomas. Nature. 627:586–593. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ng CKY, Dazert E, Boldanova T,
Coto-Llerena M, Nuciforo S, Ercan C, Suslov A, Meier MA, Bock T,
Schmidt A, et al: Integrative proteogenomic characterization of
hepatocellular carcinoma across etiologies and stages. Nat Commu.
13:24362022. View Article : Google Scholar
|
|
34
|
Calderaro J, Ziol M, Paradis V and
Zucman-Rossi J: Molecular and histological correlations in liver
cancer. J Hepatol. 71:616–630. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Villanueva A: Hepatocellular carcinoma. N
Engl J Med. 380:1450–1462. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Li X, He S and Ma B: Autophagy and
autophagy-related proteins in cancer. Mol Cancer. 19:122020.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Fan J, Ren D, Wang J, Liu X, Zhang H, Wu M
and Yang G: Bruceine D induces lung cancer cell apoptosis and
autophagy via the ROS/MAPK signaling pathway in vitro and in vivo.
Cell Death Dis. 11:1262020. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Cao Y, Wang J, Tian H and Fu GH:
Mitochondrial ROS accumulation inhibiting JAK2/STAT3 pathway is a
critical modulator of CYT997-induced autophagy and apoptosis in
gastric cancer. J Exp Clin Cancer Res. 39:1192020. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kim J, Park A, Hwang J, Zhao X, Kwak J,
Kim HW, Ku M, Yang J, Kim TI, Jeong KS, et al: KS10076, a chelator
for redox-active metal ions, induces ROS-mediated STAT3 degradation
in autophagic cell death and eliminates ALDH1+ stem cells. Cell
Rep. 40:1110772022. View Article : Google Scholar
|
|
40
|
Liang JR and Yang H: Ginkgolic acid (GA)
suppresses gastric cancer growth by inducing apoptosis and
suppressing STAT3/JAK2 signaling regulated by ROS. Biomed
Pharmacother. 125:1095852020. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zhao Z, Wang Y, Gong Y, Wang X, Zhang L,
Zhao H, Li J, Zhu J, Huang X, Zhao C, et al: Celastrol elicits
antitumor effects by inhibiting the STAT3 pathway through ROS
accumulation in non-small cell lung cancer. J Transl Med.
20:5252022. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zhou H, Li J, He Y, Xia X, Liu J and Xiong
H: SLC25A17 inhibits autophagy to promote triple-negative breast
cancer tumorigenesis by ROS-mediated JAK2/STAT3 signaling pathway.
Cancer Cell Int. 24:852024. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Garg M, Shanmugam MK, Bhardwaj V, Goel A,
Gupta R, Sharma A, Baligar P, Kumar AP, Goh BC, Wang L and Sethi G:
The pleiotropic role of transcription factor STAT3 in oncogenesis
and its targeting through natural products for cancer prevention
and therapy. Med Res Rev. December 1–2020.Epub ahead of print.
PubMed/NCBI
|
|
44
|
Hu Y, Dong Z and Liu K: Unraveling the
complexity of STAT3 in cancer: Molecular understanding and drug
discovery. J Exp Clin Cancer Res. 43:232024. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zou S, Tong Q, Liu B, Huang W, Tian Y and
Fu X: Targeting STAT3 in cancer immunotherapy. Mol Cancer.
19:1452020. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Dhanasekaran R, Deutzmann A,
Mahauad-Fernandez WD, Hansen AS, Gouw AM and Felsher DW: The MYC
oncogene-the grand orchestrator of cancer growth and immune
evasion. Nat Rev Clin Oncol. 19:23–36. 2022. View Article : Google Scholar
|
|
47
|
Duffy MJ, O'Grady S, Tang M and Crown J:
MYC as a target for cancer treatment. Cancer Treat Rev.
94:1021542021. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Lourenco C, Resetca D, Redel C, Lin P,
MacDonald AS, Ciaccio R, Kenney TMG, Wei Y, Andrews DW, Sunnerhagen
M, et al: MYC protein interactors in gene transcription and cancer.
Nat Rev Cancer. 21:579–591. 2021. View Article : Google Scholar : PubMed/NCBI
|
